Are patients ready to participate in diet intervention trials in oncology? Experience from renal cell carcinoma (RCC) patients. This is an ASCO Meeting Abstract from the 2019 Genitourinary Cancers ...

Association of disease progression, health-related quality of life (HRQoL), and utility in patients (pts) with advanced, nonfunctional, well-differentiated gastrointestinal (GI) or lung neuroendocrine ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

Measuring biochemical failure with PSA might not be appropriate in the first 2 years after external beam radiation therapy (EBRT) and hormone therapy owing to the occurrence of PSA bounce. Although ...